Skip to content

ResMed (RMD) Stock Rises 3% Following RBC Upgrade to Outperform

Published on · Source: investing.com

ResMed (RMD) Stock Rises 3% Following RBC Upgrade to Outperform

AI Summary

Summarized by AI from the source below

ResMed (RMD) experienced a stock increase of 3% after RBC Capital upgraded its rating to Outperform. This upgrade signals a more favorable outlook for the company. The increased stock price reflects investor confidence influenced by the analyst's assessment. Such upgrades can often lead to increased buying interest, which may positively impact ResMed's market performance.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

About ResMed Inc. (RMD)

ResMed makes devices for sleep apnea and respiratory care.

The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.

Earlier RMD news

RMD stock page and all news →
Share:

Get the weekly market brief

One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.

Get stories like this as they break

Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.